Fig. 2
From: Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis
Clinical relevance between tyrosine sulfation and atherosclerosis in CKD patients. Pearson’s correlation coefficients showed that concentration of O-sulfotyrosine, the metabolic end product of tyrosine sulfation, positively correlated with SYNTAX score in individuals with CKD. r = 0.4372, R2 = 0.1912, p < 0.001, Y = 7.808 × X + 221.8. CKD, chronic kidney disease